Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
28.00
-0.30 (-1.06%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Alumis Employees
As of March 31, 2026, Alumis had 227 total employees, including 225 full-time and 2 part-time employees. The number of employees increased by 3 or 1.34% since the number was last reported on December 31, 2025.
Employees
227
Change
3
Growth
1.34%
Revenue / Employee
$37,013
Profits / Employee
-$1,045,881
Market Cap
3.57B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Mar 31, 2026 | 227 | 3 | 1.34% | 225 | 2 |
| Dec 31, 2025 | 224 | 54 | 31.76% | 221 | 3 |
| Dec 31, 2024 | 170 | 61 | 55.96% | 168 | 2 |
| Dec 31, 2023 | 109 | - | - | 107 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Telix Pharmaceuticals | 1,184 |
| Arcus Biosciences | 601 |
| Denali Therapeutics | 507 |
| Arcutis Biotherapeutics | 354 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| Parabilis Medicines | 145 |
| IDEAYA Biosciences | 145 |
ALMS News
- 4 weeks ago - Alumis management to meet with Cantor - TheFly
- 6 weeks ago - Alumis rises 10.3% - TheFly
- 2 months ago - Alumis price target raised to $40 from $38 at Chardan - TheFly
- 2 months ago - Alumis Proxy statement: Proxy filing - Filings
- 2 months ago - Alumis Proxy statement: Proxy filing - Filings
- 2 months ago - Alumis price target raised to $39 from $38 at Morgan Stanley - TheFly
- 2 months ago - Alumis price target raised to $51 from $49 at Wells Fargo - TheFly
- 2 months ago - Alumis Slides: Corporate presentation - Filings